infliximab,etanercept
pfizer,amgen,janssen
['etanercept', 'infliximab']
study evaluating bc biosimilar policy proves that biosimilar etanercept and infliximab have similar treatment duration to originators, indicating comparable effectiveness and safety. #arthritisresearch #eular2023 read more: 
Leading Research. Finding Answers. Saving Lives.